The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early prediction of severe ICANS after standard-of-care CD19 CAR T-cell therapy using gradient-boosted classification trees.
 
Jennifer Jing Huang
No Relationships to Disclose
 
Emily C. Liang
Employment - Blue Lake Biotechnology (I)
Consulting or Advisory Role - Glass Health
 
Aya Albittar
No Relationships to Disclose
 
Andrew Jay Portuguese
No Relationships to Disclose
 
Natalie Wuliji
No Relationships to Disclose
 
Aiko Torkelson
No Relationships to Disclose
 
Delaney Kirchmeier
No Relationships to Disclose
 
Abigail Chutnik
No Relationships to Disclose
 
Barbara Pender
No Relationships to Disclose
 
Mazyar Shadman
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Fate therapeutics; Genentech; Genmab; Kite, a Gilead company; Lilly; Merck; MorphoSys; Nurix; Pharmacyclics; Regeneron
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene; Celgene (Inst); Genentech (Inst); Genmab (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst); Vincerx Pharma (Inst)
 
Alexandre V. Hirayama
Honoraria - Bristol-Myers Squibb/Celgene
Research Funding - Juno Therapeutics; Nektar
 
Brian G. Till
Stock and Other Ownership Interests - Proteios Technology
Consulting or Advisory Role - MustangBio; Proteios Technology
Research Funding - Juno/Bristol-Myers Sqibb; MustangBio
Patents, Royalties, Other Intellectual Property - MustangBio
 
Erik Lesley Kimble
Research Funding - Juno/Bristol-Myers Sqibb
 
Lorenzo Iovino
Stock and Other Ownership Interests - MustangBio
 
Aude Chapuis
No Relationships to Disclose
 
Folashade Otegbeye
No Relationships to Disclose
 
Ryan Daniel Cassaday
Employment - Seagen (I)
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Kite, a Gilead company; Pfizer
Consulting or Advisory Role - Amgen; Autolus; Jazz Pharmaceuticals; Kite/Gilead; Pfizer
Research Funding - Amgen (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Pfizer; SERVIER (Inst); Vanda Pharmaceuticals
Travel, Accommodations, Expenses - Kite, a Gilead company
Other Relationship - Autolus; Pepromene
 
Filippo Milano
No Relationships to Disclose
 
David G. Maloney
Honoraria - Amgen; Bristol-Myers Squibb; Genentech/Roche; Gilead Sciences; Incyte; Janssen; Juno Therapeutics; Kite, a Gilead Company; Legend Biotech; MorphoSys; MustangBio; Novartis; Pharmacyclics; Umoja Biopharma
Consulting or Advisory Role - A2 Biotherapeutics; Celgene/Bristol-Myers Squibb; Genentech; NAVAN Technologies
Research Funding - Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead Company (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on 4 provisional patents
 
Jordan Gauthier
Honoraria - Janssen; Kite, a Gilead Company; Legend Biotech; SOBI
Consulting or Advisory Role - Janssen; Kite, a Gilead Company; Legend Biotech; MorphoSys; SOBI
Research Funding - Angiocrine Bioscience; Celgene/Bristol-Myers Squibb; Juno/Bristol-Myers Sqibb; MorphoSys; SOBI
Other Relationship - Century Therapeutics